Juvisé Pharmaceuticals
PrivateLast Round
Debt
Feb 9, 2026
Total Funding Raised
$889M
Company Overview
Juvisé Pharmaceuticals is a specialty pharmaceutical company that acquires and markets essential medicines in therapeutic areas including oncology, cardiology, gastroenterology, and neuroscience.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juvisé Pharmaceuticals Comparables
Compare Juvisé Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmanovia | 86% | |
| CHEPLAPHARM Arzneimittel GmbH | 85% | |
| Essential Pharma | 84% |
For institutional investors. Book with your work email.
Juvisé Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 9, 2026 | ||||
| Private Equity | Mar 26, 2024 | ||||
| Debt | Feb 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Juvisé Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hayfin Capital Management | Debt |
| Pemberton Asset Management | Private Equity |
| Bpifrance | Private Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 53% MoM.
- May 11, 2025
Grew 23% QoQ, from 71 to 87 employees.
For institutional investors. Book with your work email.
Juvisé Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Juvisé Pharmaceuticals's valuation, stock price, and market status.
Is Juvisé Pharmaceuticals a public or private company?
Juvisé Pharmaceuticals is a private company.
What is the current stock price of Juvisé Pharmaceuticals?
Juvisé Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Juvisé Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Juvisé Pharmaceuticals worth (valuation)?
Valuation information for Juvisé Pharmaceuticals is not publicly available.
Can I buy Juvisé Pharmaceuticals stock?
Juvisé Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Juvisé Pharmaceuticals's last funding round?
Juvisé Pharmaceuticals's most recent funding round was Debt on February 9, 2026.
Who are the main investors in Juvisé Pharmaceuticals?
Key investors in Juvisé Pharmaceuticals include Hayfin Capital Management.
Will Juvisé Pharmaceuticals IPO soon?
No public IPO plans have been announced for Juvisé Pharmaceuticals.
How can I track Juvisé Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Juvisé Pharmaceuticals's shares on secondary markets.